{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:24:10Z","timestamp":1785165850296,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Science and Technology of the Republic of China"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.actbio.2019.01.065","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T11:45:13Z","timestamp":1549021513000},"page":"207-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration"],"prefix":"10.1016","volume":"87","author":[{"given":"Yung-Chih","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendiran","family":"Rajesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2019.01.065_b0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","article-title":"Therapeutic strategies for Alzheimer\u2019s disease in clinical trials","volume":"68","author":"Godyn","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.actbio.2019.01.065_b0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2019.01.065_b0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.actbio.2019.01.065_b0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jnr.10328","article-title":"Paradigm shifts in Alzheimer\u2019s disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies","volume":"69","author":"Kirkitadze","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.actbio.2019.01.065_b0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000330363","article-title":"Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer\u2019s disease","volume":"9","author":"Biscaro","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.actbio.2019.01.065_b0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1196\/annals.1332.006","article-title":"Microglia as a potential bridge between the amyloid \u03b2-peptide and tau","volume":"1035","author":"Kitazawa","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.actbio.2019.01.065_b0035","doi-asserted-by":"crossref","first-page":"8501693","DOI":"10.1155\/2016\/8501693","article-title":"Current research therapeutic strategies for Alzheimer\u2019s disease treatment","volume":"2016","author":"Folch","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.actbio.2019.01.065_b0040","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1128\/MCB.25.19.8520-8530.2005","article-title":"Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species","volume":"25","author":"Storz","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.actbio.2019.01.065_b0045","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jnr.20025","article-title":"Curcumin has potent anti-amyloidogenic effects for Alzheimer\u2019s \u03b2-amyloid fibrils in vitro","volume":"75","author":"Ono","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.actbio.2019.01.065_b0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuropharm.2015.01.027","article-title":"The flavonoid quercetin ameliorates Alzheimer\u2019s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer\u2019s disease model mice","volume":"93","author":"Sabogal-Guaqueta","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.actbio.2019.01.065_b0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0007114515004687","article-title":"Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer\u2019s disease","volume":"115","author":"Goozee","year":"2016","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.actbio.2019.01.065_b0060","first-page":"229","article-title":"Effect of plant extracts on Alzheimer\u2019s disease: an insight into therapeutic avenues","volume":"121","author":"Obulesu","year":"2011","journal-title":"J. Neurosci. Rural Pract."},{"key":"10.1016\/j.actbio.2019.01.065_b0065","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1124\/jpet.105.099317","article-title":"The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-\u03b2 peptide-induced neurotoxicity","volume":"317","author":"Iuvone","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.actbio.2019.01.065_b0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbr.2007.03.001","article-title":"A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by A\u03b225-35","volume":"180","author":"Alkam","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.actbio.2019.01.065_b0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2019.01.065_b0080","doi-asserted-by":"crossref","first-page":"469679","DOI":"10.1155\/2011\/469679","article-title":"Liposomes for targeted delivery of active agents against neurodegenerative diseases","volume":"2011","author":"Spuch","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.actbio.2019.01.065_b0085","first-page":"123","article-title":"Fate and behavior of liposomes in vivo: a review of controlling factors","volume":"3","author":"Senior","year":"1987","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.actbio.2019.01.065_b0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejpb.2007.01.020","article-title":"Development, characterization and in vivo evaluation of benzocaine-loaded liposomes","volume":"67","author":"Mura","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2019.01.065_b0095","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1073\/pnas.0435906100","article-title":"Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes","volume":"100","author":"Torchilin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.actbio.2019.01.065_b0100","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1073\/pnas.151247498","article-title":"TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors","volume":"98","author":"Torchilin","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.actbio.2019.01.065_b0105","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.addr.2007.10.008","article-title":"TAT peptide-mediated intracellular delivery of pharmaceutical nanocarriers","volume":"60","author":"Torchilin","year":"2008","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.actbio.2019.01.065_b0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpharm.2011.09.008","article-title":"Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals","volume":"420","author":"Qin","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2019.01.065_b0115","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.biomaterials.2007.11.014","article-title":"Biologically active core\/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood\u2013brain barrier","volume":"29","author":"Liu","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.01.065_b0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13346-015-0220-8","article-title":"Influence of cholesterol on liposome stability and on in vitro drug release","volume":"5","author":"Briuglia","year":"2015","journal-title":"Drug. Deliv. Transl. Res."},{"key":"10.1016\/j.actbio.2019.01.065_b0125","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.bpj.2015.04.010","article-title":"Interactions of the anticancer drug tamoxifen with lipid membranes","volume":"108","author":"Khadka","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.actbio.2019.01.065_b0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12010-012-9724-6","article-title":"Investigation of factors affecting controlled release from photosensitive DMPC and DSPC liposomes","volume":"167","author":"Aygun","year":"2012","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.actbio.2019.01.065_b0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10717540490265243","article-title":"The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations","volume":"11","author":"Anderson","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.actbio.2019.01.065_b0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbamem.2012.10.022","article-title":"Nanoencapsulation of quercetin and resveratrol into elastic liposomes","volume":"28","author":"Cadena","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.actbio.2019.01.065_b0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2010.01.003","article-title":"Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone","volume":"388","author":"Bhardwaj","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2019.01.065_b0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuint.2008.12.002","article-title":"A new blood\u2013brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes","volume":"54","author":"Nakagawa","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.actbio.2019.01.065_b0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.colsurfb.2012.06.002","article-title":"Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia","volume":"101","author":"Kuo","year":"2013","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.actbio.2019.01.065_b0160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijpharm.2011.06.030","article-title":"Curcumin and its nano-formulation: the kinetics of tissue distribution and blood\u2013brain barrier penetration","volume":"416","author":"Tsai","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2019.01.065_b0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1242\/jcs.97.1.127","article-title":"Adsorptive endocytosis and membrane recycling by cultured primary bovine brain microvessel endothelial cell monolayers","volume":"97","author":"Raub","year":"1990","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.actbio.2019.01.065_b0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jnutbio.2008.03.002","article-title":"Protective effect of quercetin in primary neurons against A\u03b2(1\u201342): relevance to Alzheimer\u2019s disease","volume":"20","author":"Ansari","year":"2009","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.actbio.2019.01.065_b0175","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1124\/jpet.105.099317","article-title":"The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-\u03b2 peptide-induced neurotoxicity","volume":"317","author":"Iuvone","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.actbio.2019.01.065_b0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0014-4886(02)00059-6","article-title":"H2O2 and 4-hydroxynonenal mediate amyloid \u03b2-induced neuronal apoptosis by activating JNKs and p38 MAPK","volume":"180","author":"Tamagno","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.actbio.2019.01.065_b0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/biof.5520340208","article-title":"Lipid peroxidation products as oxidative stress biomarkers","volume":"34","author":"Niki","year":"2008","journal-title":"Biofactors"},{"key":"10.1016\/j.actbio.2019.01.065_b0190","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.embor.7400755","article-title":"MAPK signalling: ERK5 versus ERK1\/2","volume":"7","author":"Nishimoto","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.actbio.2019.01.065_b0195","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1038\/tp.2012.119","article-title":"Integrated copy number and gene expression analysis detects a CREB1 association with Alzheimer\u2019s disease","volume":"2","author":"Li","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.actbio.2019.01.065_b0200","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1039\/C6CS00076B","article-title":"Blood\u2013brain barrier shuttle peptides: an emerging paradigm for brain delivery","volume":"45","author":"Oller-Salvia","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2019.01.065_b0205","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.108.137455","article-title":"Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer\u2019s disease","volume":"326","author":"Begum","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.actbio.2019.01.065_b0210","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.nano.2013.12.001","article-title":"Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect A\u03b2 aggregation features and cross the blood\u2013brain-barrier: Implications for therapy of Alzheimer disease","volume":"10","author":"Bana","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actbio.2019.01.065_b0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0168-0102(02)00201-8","article-title":"Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid \u03b2-peptide","volume":"45","author":"Melo","year":"2003","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.actbio.2019.01.065_b0220","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jtice.2017.05.011","article-title":"A critical overview of therapeutic strategy and advancement for Alzheimer\u2019s disease treatment","volume":"77","author":"Kuo","year":"2017","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.actbio.2019.01.065_b0225","first-page":"21","article-title":"Nasal administration of quercetin liposomes modulate cognitive impairment and inhibit acetylcholinesterase activity in hippocampus","volume":"1","author":"Tong-Un","year":"2010","journal-title":"Am. J. Neurosci."},{"key":"10.1016\/j.actbio.2019.01.065_b0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cbf.3014","article-title":"Rosmarinic acid prevents lipid peroxidation and increase in acetylcholinesterase activity in brain of streptozotocin-induced diabetic rats","volume":"32","author":"Mushtaq","year":"2014","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.actbio.2019.01.065_b0235","doi-asserted-by":"crossref","first-page":"931251","DOI":"10.1155\/2013\/931251","article-title":"Evidence in support of potential applications of lipid peroxidation products in cancer treatment","volume":"2013","author":"Erejuwa","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.actbio.2019.01.065_b0240","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cbi.2008.04.047","article-title":"Association between acetylcholinesterase and \u03b2-amyloid peptide in Alzheimer\u2019s cerebrospinal fluid","volume":"175","author":"Garc\u00eda-Ayllon","year":"2008","journal-title":"Chem. Biol. Interact."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270611930087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270611930087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:13:12Z","timestamp":1761671592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S174270611930087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":48,"alternative-id":["S174270611930087X"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2019.01.065","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2019.01.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}